IL33 and pulmonary fibrosis: Two methods of ILC2 depletion were employed to determine the contribution of ILC2s in HPS-lung fibrosis: an IL-33 siRNA to knock down the expression of IL-33 and Rorafl/flIL-7Rcre mice, in which ILC2s are depleted (49–51).